Sudeep Pharma Limited (NSE:SUDEEPPHRM)
India · Delayed Price · Currency is INR 780.50
+38.35 (5.17%)
Jun 1, 2026, 3:30 PM IST
Sudeep Pharma Revenue
In the fiscal year ending March 31, 2026, Sudeep Pharma had annual revenue of 6.42B INR with 27.94% growth. Sudeep Pharma had revenue of 1.82B in the quarter ending March 31, 2026, with 15.74% growth.
Revenue
6.42B
Revenue Growth
+27.94%
P/S Ratio
13.05
Revenue / Employee
13.38M
Employees
740
Market Cap
83.82B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 6.42B | 1.40B | 27.94% |
| Mar 31, 2025 | 5.02B | 427.19M | 9.30% |
| Mar 31, 2024 | 4.59B | 305.42M | 7.12% |
| Mar 31, 2023 | 4.29B | 841.21M | 24.41% |
| Mar 31, 2022 | 3.45B | 3.38B | 4,999.06% |
| Mar 31, 2004 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2003 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Alembic Pharmaceuticals | 73.45B |
| Strides Pharma Science | 48.59B |
| NATCO Pharma | 43.76B |
| Akums Drugs and Pharmaceuticals | 43.59B |
| Alivus Life Sciences | 25.52B |
| Cohance Lifesciences | 22.69B |
| Aarti Pharmalabs | 18.29B |
| Innova Captab | 16.30B |